Inventor · disambiguated record
Louise Edwards
Also filed as: EDWARDS LOUISE · EDWARDS LOUISE G
37 granted patents·38 pending applications·597 citations·filing 1996–2018
98Inventor score
Top patents by PatentIndex Score
75 records- 0196US7112595B2Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2003·Granted Sep 26, 2006·92 cites·23 claims
- 0295US8263596B2Kinase inhibitors and method of treating cancerSAMPSON PETER B·Filed 2011·Granted Sep 11, 2012·26 cites·10 claims
- 0394US9139563B2Kinase inhibitors and method of treating cancerUNIV HEALTH NETWORK·Filed 2013·Granted Sep 22, 2015·14 cites·9 claims
- 0494US8481533B2Kinase inhibitors and method of treating cancerSAMPSON PETER B·Filed 2012·Granted Jul 9, 2013·24 cites·20 claims
- 0593US7585881B2Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Sep 8, 2009·36 cites·2 claims
- 0692US9907800B2Kinase inhibitors and method of treating cancerUNIV HEALTH NETWORK·Filed 2015·Granted Mar 6, 2018·7 cites·6 claims
- 0791US8481525B2Kinase inhibitors and method of treating cancer with sameSAMPSON PETER BRENT·Filed 2010·Granted Jul 9, 2013·27 cites·33 claims
- 0890US10358436B2Kinase inhibitors and method of treating cancerUNIV HEALTH NETWORK·Filed 2018·Granted Jul 23, 2019·4 cites·6 claims
- 0990US8999968B2Kinase inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2013·Granted Apr 7, 2015·13 cites·13 claims
- 1089US8921545B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesCUMMING GRAHAM·Filed 2011·Granted Dec 30, 2014·15 cites·14 claims
- 1189US6686374B1Azaindoles having serotonin receptor affinityNPS ALLELIX CORP·Filed 2000·Granted Feb 3, 2004·24 cites·10 claims
- 1288US5998438A5-cyclo indole compoundsALLELIX BIOPHARMA·Filed 1997·Granted Dec 7, 1999·49 cites·40 claims
- 1387US9796703B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesUNIV HEALTH NETWORK·Filed 2017·Granted Oct 24, 2017·4 cites·9 claims
- 1487US7960422B2Pharmaceutically active compounds containing tetrazolyl and triazolyl ringsASTRAZENECA AB·Filed 2008·Granted Jun 14, 2011·11 cites·2 claims
- 1586USRE47731EKinase inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2018·Granted Nov 19, 2019·4 cites·13 claims
- 1686US9579327B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesUNIV HEALTH NETWORK·Filed 2014·Granted Feb 28, 2017·5 cites·16 claims
- 1786US6133287APiperidine-indole compounds having 5-HT6 affinityALLELIX BIOPHARMA·Filed 1998·Granted Oct 17, 2000·38 cites·19 claims
- 1885US7476684B2Compounds for the treatment of neurological, psychiatric or pain disordersASTRAZENECA AB·Filed 2006·Granted Jan 13, 2009·11 cites·5 claims
- 1985US7268127B2Azaindoles having serotonin receptor affinityNPS ALLELIX CORP·Filed 2005·Granted Sep 11, 2007·5 cites·7 claims
- 2085US5856510A5-alkenyl and 5-alkynyl indole compoundsALLELIX BIOPHARMA·Filed 1996·Granted Jan 5, 1999·38 cites·30 claims
- 2183US10077255B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesUNIV HEALTH NETWORK·Filed 2017·Granted Sep 18, 2018·2 cites·25 claims
- 2283US7074809B2CompoundsNPS PHARMA INC·Filed 2003·Granted Jul 11, 2006·23 cites·12 claims
- 2383US6916818B2Azaindoles having serotonin receptor affinityNPS ALLELIX CORP·Filed 2003·Granted Jul 12, 2005·12 cites·5 claims
- 2483US6635639B2Use of N-alkylamino-heterocylic compounds for the treatment of migraineNPS ALLELIX CORP·Filed 2002·Granted Oct 21, 2003·20 cites·15 claims
- 2582US7456200B2CompoundsASTRAZENECA AB·Filed 2005·Granted Nov 25, 2008·9 cites·11 claims
- 2678US6100291APyrrolidine-indole compounds having 5-HT6 affinityALLELIX BIOPHARMA·Filed 1998·Granted Aug 8, 2000·23 cites·23 claims
- 2776US6716837B1Heterocyclic compounds for the treatment of migraineNPS ALLELIX BIOPHARMACEUTICALS·Filed 2000·Granted Apr 6, 2004·13 cites·20 claims
- 2875US7772235B2mGluR5 modulatorsASTRAZENECA AB·Filed 2007·Granted Aug 10, 2010·2 cites·6 claims
- 2974US8148394B2Azaindoles having serotonin receptor affinityEDWARDS LOUISE·Filed 2007·Granted Apr 3, 2012·2 cites·16 claims
- 3074US7678796B2MGluR5 modulators IASTRAZENECA AB·Filed 2007·Granted Mar 16, 2010·3 cites·21 claims
- 3172US7576077B2Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Aug 18, 2009·2 cites·16 claims
- 3268US6191141B1Azaindoles having serotonin receptor affinityNPS ALLELIX CORP·Filed 1999·Granted Feb 20, 2001·26 cites·8 claims
- 3362US2007293545A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 3462US2008015204A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 3562US2008045571A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 3662US2008015234A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 3757US2007179188A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 3856US6380242B1N-alkylamino-indoles for the treatment of migraineNPS ALLELIX CORP·Filed 1999·Granted Apr 30, 2002·11 cites·8 claims
- 3953US2012302596A1Azaindoles having serotonin receptor affinityEDWARDS LOUISE·Filed 2012·Application pending·0 cites
- 4053US2007270469A1New compounds for the treatment of neurological, psychiatric or pain disordersMINIDIS ALEXANDER·Filed 2007·Application pending·0 cites
- 4153US2007270468A1New compounds for the treatment of neurological, psychiatric or pain disordersMINIDIS ALEXANDER·Filed 2007·Application pending·0 cites
- 4252US2008312246A1Substituted Piperazines as Metabotropic Glutamate Receptor AntagonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4352US2008312240A1Bicyclic Piperazines as Metabotropic Glutatmate Receptor AntagonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4452US2007037820A1Substituted piperazines as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2006·Application pending·0 cites
- 4552US2007037816A1Bicyclic piperazines as metabotropic glutatmate receptor antagonistsNPS PHARMA INC·Filed 2006·Application pending·0 cites
- 4651US2007037817A1Acetylenic piperazines as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2006·Application pending·0 cites
- 4750US2008194571A1Acetylenic Piperazines as Metabotropic Glutamate Receptor AntagonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4849US7691892B2Tetrazole compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Apr 6, 2010·0 cites·22 claims
- 4948US2006019997A1Triazole compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 5048US2007185178A1Triazole compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →